Palantir's Pop Was Mechanical. The Pause Is the Signal.

Start with what actually happened. Consensus going in was for revenue near $1.81 billion and adjusted EPS around $0.34 to $0.35, itself implying roughly 81% year over year growth. $PLTR delivered $1.94 billion in revenue, up 93%, its fastest growth rate on record, and adjusted EPS of $0.41, with GAAP EPS matching it exactly, up from $0.13 a year earlier on net income of roughly $1.06 billion versus about $327 million in the year ago quarter. US commercial revenue jumped 149% to $764 million, a figure CEO Alex Karp's team says has compounded roughly 380% since 2024. US government revenue grew 90% to $809 million, quieting the worry that defense-contract lumpiness would eventually catch up with that segment. Combined US revenue reached $1.573 billion, up 115%. The company closed 220 deals worth at least $1 million in the quarter, 73 of them worth at least $10 million, and total contract value rose 49% to $3.37 billion.

Guidance moved by more than a rounding error too. Full year 2026 revenue guidance rose from roughly $7.65 billion to $8.15 billion to $8.158 billion, about 82% growth. US commercial guidance rose from about $3.22 billion to in excess of $3.424 billion, at least 134% growth. Adjusted operating income guidance climbed to $4.889 billion to $4.897 billion, adjusted free cash flow guidance to $4.5 billion to $4.7 billion, and Q3 revenue guidance of $2.16 billion to $2.164 billion came in well above the roughly $2 billion analysts were modeling. The company's combined growth-plus-margin score, its version of the Rule of 40, hit 155%, a 10 point sequential jump and the 12th straight quarter that score has expanded. Operating cash flow was $1.216 billion and adjusted free cash flow $1.22 billion, a 63% margin, with $9.2 billion in cash and short-term treasuries on the balance sheet. Karp's own framing to CNBC was blunt: "Forget consensus."

None of that is in dispute. What's worth separating is the size of the stock move from the size of the surprise, because the two are only loosely related here. A beat that large against an already-elevated bar triggered real short covering: Bloomberg's S3 Partners estimated short sellers lost roughly $3 billion in paper gains in that single session. Cathie Wood's $ARKK and $ARKF funds sold a combined 39,233 shares, worth about $6.4 million, into the rally the next day rather than adding to the position, a detail worth noting from one of the stock's earliest and most vocal bulls. Karp's own net worth rose an estimated $3.1 billion to $15.3 billion on the move, enough to jump him 67 spots up the Forbes billionaire ranking.

The reason the size of the pop matters is the math investors are now underwriting. Using that SEC-anchored market cap against the newly raised full year guidance, the stock trades near 47 times projected 2026 sales, and around 167 times trailing GAAP earnings on roughly $2.28 billion of trailing twelve month net income. That's a richer multiple than it was Monday morning, not cheaper, because the price moved faster than the guidance did. Wall Street is split on whether that's still reasonable. Deutsche Bank's Brad Zelnick upgraded the stock to buy and lifted his price target from $80 to $200. A separate research note cited by Proactive Investors put the stock at about 44 times its revised 2027 free cash flow estimate and called it undervalued on that basis, raising its target to $220. Jefferies' Brent Thill also raised his target, but only to $80 from $70, a far more conservative read of the same quarter. Citi's take, per CNBC, was that the results "further weaken the bear case around rising AI competition." All of those views can be true at once: a real business growing faster than almost any software company its size, priced for several more years of exactly this, not for a single good quarter.

The reaction wasn't contained to one stock either. The Nasdaq rose 2.59% Tuesday, the Dow gained 907 points, and the S&P's information technology sector was up 4% on the session, with Micron up more than 7% and Marvell up nearly 13% the same day, chip names benefiting from renewed AI-capex enthusiasm rather than anything specific to $PLTR's own numbers. That's the fragile part of the mechanism: one company's earnings did a lot of the emotional work of repricing enthusiasm for the group for an afternoon, which means the next disappointing print from any adjacent AI name carries outsized power to reverse it.

There's a second variable the stock's momentum is mostly ignoring, and it has nothing to do with revenue growth. Government filings and multiple news outlets have documented Palantir's $30 million ImmigrationOS contract with US Immigration and Customs Enforcement, a prototype delivered in September 2025 under a contract running through September 2027, plus a separate tool called ELITE that a congressional letter says draws on Department of Health and Human Services data for targeting. None of that shows up in a revenue or EPS line item, but it is the kind of exposure that has periodically drawn public pension fund scrutiny and headline risk for government-facing contractors, independent of how fast the commercial book is growing. It's a tail risk, not a base case, but at more than 150 times trailing earnings there's not much room in the valuation to absorb a genuine tail event if one arrives.

None of this argues the quarter was hollow. It wasn't. A 93% growth rate, 149% US commercial growth, a 155 score on the company's own growth-plus-margin metric, and GAAP profitability at this scale together describe a real business, not a story stock running on narrative. The honest read is narrower than either the bulls or bears want it to be: Tuesday proved $PLTR can keep converting AI demand into recognized revenue and cash flow right now, at a pace almost nothing else in enterprise software is matching. It did not prove the multiple was cheap, and it raised, rather than lowered, the bar for what "still growing" needs to look like from here. The actual test is Q3, whether US commercial growth can hold anywhere near triple digits against a much harder year-over-year comparison, not whether the market can be persuaded to reward the same story a second time.

If you want to check any of this yourself rather than take an analyst's word for it, stocks-llm.com/?q=which software companies trade above 40 times sales shows how crowded that valuation tier really is right now. And stocks-llm.com/?q=compare PLTR revenue growth profitability and valuation to enterprise software peers lets you pull the underlying numbers side by side instead of trusting any single writeup, including this one.